Related Experiment Videos
The proteasome inhibitor PI31 competes with PA28 for binding to 20S proteasomes
D M Zaiss1, S Standera, H Holzhütter
1Institute of Biochemistry/Charité, Monbijou Strasse 2, D-10117, Berlin, Germany.
FEBS Letters
|September 3, 1999
Abstract:
PI31 is a previously described inhibitor of 20S proteasomes. Using recombinant PI31 we have analyzed its effect on proteasomal hydrolyzing activity of short fluorogenic substrates and of a synthetic 40-mer polypeptide. In addition, we investigated its influence on the activation of 20S proteasome by the proteasome activator PA28. PI31 inhibits polypeptide degradation already at concentrations which only partially inhibit fluorogenic substrate turnover and immunosubunits do not influence the PI31 binding affinity. Furthermore our data demonstrate that PI31 is a potent competitor of PA28-mediated activation.